(redirected from Invasive Pneumococcal Disease)
IPDInfrastructure Planning and Design (Microsoft)
IPDIntegrated Project Delivery
IPDInstruction and Professional Development (various organizations)
IPDInstituto Peruano del Deporte (Spanish: Peruvian Institute of Sport; Peru)
IPDInternally Displaced Person
IPDInteractive Pen Display (computer equipment)
IPDInstitut für Programmstrukturen und Datenorganisation
IPDInvasive Pneumococcal Disease
IPDIntegrated Product Development
IPDInvestment Property Databank (UK)
IPDInternet Pinball Database
IPDInstitute for Professional Development
IPDInternal Pointing Device
IPDIdentifier Process Declaration
IPDInternet Protocol Deffered
IPDInternational Product Development
IPDIndependence Police Department (Independence, MO)
IPDImplicit Price Deflator
IPDIntellectual Property Department
IPDIndividual Patient Data
IPDInnovative Product Development (various organizations)
IPDInstitute for Popular Democracy (Philippines)
IPDInterpupillary Distance (binocular optics)
IPDIntegrated Passive Device (electronics)
IPDInstitute of Personnel and Development
IPDIndianapolis Police Department
IPDImage Process Design (various locations)
IPDIdiopathic Parkinson's Disease
IPDInterspinous Process Decompression (spinal stenosis treatment)
IPDInstitute of Peace and Democracy (various locations)
IPDIndustrial Power Distribution (UK)
IPDIn-Patient Department
IPDImmediate Pigment Darkening
IPDInfectious and Parasitic Disease
IPDIndustrial Park District (Kentucky)
IPDImpulse for Progress and Democracy (Benin)
IPDInformation Processing Division (NOAA)
IPDInternational Property Directory (various locations)
IPDIn-Plane Distortion
IPDIntelligent Power Device
IPDInternational Policy Division (various locations)
IPDInsider Presse Dienst (Basel, Switzerland)
IPDInterim Program Director (various locations)
IPDIncidence and Prevalence Database
IPDIntel Product Dealer
IPDInline-Progression-Dimension (Apache)
IPDIssue Priority Designator
IPDInfrastructure Protection Division (US FEMA)
IPDIntelligent Printer Data
IPDImmature Personality Disorder
IPDInstitute of Policy Development (Singapore)
IPDIrving Police Department (Irving, Texas)
IPDInternational Parking Design, Inc.
IPDInterest Payment Date
IPDInvestment Products Division
IPDInternational Personal Development (human resource development company)
IPDImproved Point Defense
IPDInformation and Publishing Division
IPDInteractive Phase Distortion (modulation)
IPDInfel Phira Dependent (gaming)
IPDIntellectual Property Development, Inc. (Bay Harbor Islands, FL)
IPDIn Patients Department
IPDIndio Police Department (Indio, CA)
IPDIBM Personal Dictation System
IPDInformation Product Description
IPDImprovement Portfolio Development
IPDInteraural Pitch Difference
IPDInstitutional Participation Division (US Department of Education)
IPDInternational Product Development Co., Inc.
IPDIntelligent Product Data
IPDIntentional Packet Dropping
IPDIntegral Protective Device
IPDImplementing Project Directive
IPDIn Pace Domini (Latin: In Peace of the Lord, epigraphy)
IPDImage Product Database
IPDInstructional Program Developer/Development
IPDInpatient Director (Kaiser Permanente)
IPDIn Praesentia Dominorum (Latin: In Presence of the Lords (of Session))
IPDInternational Program Directive
References in periodicals archive ?
Factors predicting mortality in invasive pneumococcal disease in adults in Alberta.
Today, many of these potentially dangerous infections, like invasive pneumococcal disease, are still occurring in the U.
NYSE: PFE), in partnership with Parents magazine (NYSE: MDP), has provided results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough, and invasive pneumococcal disease, and the measures parents can take to help prevent them, the company said.
All these variables, fitting within the framework of high clinical suspicion, led in this case of invasive pneumococcal disease, to a survival outcome.
Invasive pneumococcal disease can appear as pneumonia, blood infection (bacteremia or sepsis), meningitis, or middle-ear infection.
Healthcare company Pfizer (NYSE:PFE) revealed on Monday the the World Health Organisation (WHO) has prequalified its four-dose, multi-dose vial (MDV) presentation of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13 - valent, adsorbed]) in the developing world to help protect against invasive pneumococcal disease.
The use of the same vaccine in the elderly-65 years old and above-was further supported by the recently published Capita study which showed the efficacy of the vaccine in preventing the first episode of vaccine-type community-acquired pneumonia and invasive pneumococcal disease.
3] recently demonstrated an 89% reduction in the incidence of invasive pneumococcal disease by PCV7 serotypes within 4 years of their introduction among vaccinated children <2 years of age (direct effect), and a 57% reduction among unvaccinated adults 25-44 years of age (indirect effect).
In the per-protocol analysis, vaccine efficacy was 46% for preventing a first episode of vaccine-type community-acquired pneumonia, 45% for preventing nonbacteremic and noninvasive vaccine-type community-acquired pneumonia, and 75% for preventing vaccine-type invasive pneumococcal disease.
6% for pneumonia and 75% for invasive pneumococcal disease.
85) in the absolute number of invasive pneumococcal disease (IPD) cases in children aged under 5 years but a 17% increase in the proportion of cases in children with comorbidities such as chronic lung disease, malignancy, or immunosuppressive therapy.
After the introduction of the Prevnar pneumococcal conjugated vaccine in 2000, a dramatic decrease in invasive pneumococcal disease was observed within 1 year.
Full browser ?